MCID: TRP005
MIFTS: 37

Trophoblastic Neoplasm

Categories: Cancer diseases

Aliases & Classifications for Trophoblastic Neoplasm

MalaCards integrated aliases for Trophoblastic Neoplasm:

Name: Trophoblastic Neoplasm 12 15
Trophoblastic Neoplasms 77 45 74
Trophoblastic Tumor 12 77 56

Classifications:



External Ids:

Disease Ontology 12 DOID:4085
MeSH 45 D014328
NCIt 51 C3422
UMLS 74 C0041182

Summaries for Trophoblastic Neoplasm

Disease Ontology : 12 A germ cell and embryonal cancer that derives from trophoblastic tissue.

MalaCards based summary : Trophoblastic Neoplasm, also known as trophoblastic neoplasms, is related to gestational trophoblastic neoplasm and hydatidiform mole, recurrent, 1. An important gene associated with Trophoblastic Neoplasm is H19 (H19 Imprinted Maternally Expressed Transcript). The drugs Nitroglycerin and Methotrexate have been mentioned in the context of this disorder. Affiliated tissues include placenta, bone marrow and brain.

Wikipedia : 77 Gestational trophoblastic disease (GTD) is a term used for a group of pregnancy-related tumours. These... more...

Related Diseases for Trophoblastic Neoplasm

Diseases related to Trophoblastic Neoplasm via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 60)
# Related Disease Score Top Affiliating Genes
1 gestational trophoblastic neoplasm 33.7 CSH1 H19
2 hydatidiform mole, recurrent, 1 32.4 CGA H19
3 placental site trophoblastic tumor 31.5 CSH1 INHA LNPEP
4 epithelioid trophoblastic tumor 29.8 CSH1 INHA
5 choriocarcinoma 29.2 CGA CSH1 H19 LNPEP
6 testicular trophoblastic tumor 12.3
7 gestational trophoblastic tumor 11.4
8 recurrent hydatidiform mole 11.2
9 ectopic pregnancy 10.1
10 teratoma 10.1
11 germ cells tumors 10.1
12 orofaciodigital syndrome viii 10.1 CGA INHA
13 breast cancer 10.0
14 arteriovenous malformation 10.0
15 leiomyoma 10.0
16 partial hydatidiform mole 10.0
17 gestational choriocarcinoma 10.0 CSH1 H19
18 germ cell cancer 10.0 CGA H19
19 robinow syndrome 10.0 CGA INHA
20 pneumothorax 10.0
21 squamous cell carcinoma 10.0
22 adenocarcinoma 10.0
23 mixed germ cell tumor 10.0
24 seminoma 10.0 CGA INHA
25 placenta disease 9.9 CGA CSH1
26 klippel-trenaunay-weber syndrome 9.9
27 pleurisy 9.9
28 nephrotic syndrome 9.9
29 hypothyroidism 9.9
30 placenta accreta 9.9
31 adrenocortical carcinoma, hereditary 9.8 H19 INHA
32 silver-russell syndrome 9.8 CSH1 H19
33 systemic lupus erythematosus 9.8
34 small cell cancer of the lung 9.8
35 suppressor of tumorigenicity 3 9.8
36 lung cancer 9.8
37 pulmonary arteriovenous fistulas 9.8
38 testicular germ cell tumor 9.8
39 testicular germ cell tumor 1 9.8
40 cervical cancer 9.8
41 alopecia 9.8
42 arteriovenous fistula 9.8
43 placenta praevia 9.8
44 respiratory failure 9.8
45 amenorrhea 9.8
46 fallopian tube carcinoma 9.8
47 pulmonary tuberculosis 9.8
48 mucinous adenocarcinoma 9.8
49 embryonal carcinoma 9.8
50 appendix adenocarcinoma 9.8

Graphical network of the top 20 diseases related to Trophoblastic Neoplasm:



Diseases related to Trophoblastic Neoplasm

Symptoms & Phenotypes for Trophoblastic Neoplasm

Drugs & Therapeutics for Trophoblastic Neoplasm

Drugs for Trophoblastic Neoplasm (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 188)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Nitroglycerin Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 55-63-0 4510
2
Methotrexate Approved Phase 2, Phase 3,Phase 3,Not Applicable 1959-05-2, 59-05-2 126941
3
leucovorin Approved Phase 2, Phase 3,Phase 3,Phase 1 58-05-9 143 6006
4
Levoleucovorin Approved, Investigational Phase 2, Phase 3,Phase 3,Phase 1 68538-85-2
5
Dactinomycin Approved, Investigational Phase 3,Phase 2 50-76-0 457193 2019
6
Amifostine Approved, Investigational Phase 3 20537-88-6 2141
7
Caspofungin Approved Phase 3,Phase 2 162808-62-0, 179463-17-3 2826718 468682
8
Amphotericin B Approved, Investigational Phase 3 1397-89-3 5280965 14956
9
Miconazole Approved, Investigational, Vet_approved Phase 3,Phase 2,Not Applicable 22916-47-8 4189
10
Captopril Approved Phase 3 62571-86-2 44093
11
Cyclophosphamide Approved, Investigational Phase 3,Phase 2,Not Applicable 50-18-0, 6055-19-2 2907
12
Ribavirin Approved Phase 3 36791-04-5 37542
13
Palivizumab Approved, Investigational Phase 3 188039-54-5
14
Fluconazole Approved, Investigational Phase 3 86386-73-4 3365
15
Itraconazole Approved, Investigational Phase 3,Not Applicable 84625-61-6 55283
16
Acyclovir Approved Phase 3 59277-89-3 2022
17
Bleomycin Approved, Investigational Phase 3 11056-06-7 5360373
18
Etoposide Approved Phase 3,Phase 1 33419-42-0 36462
19
Cisplatin Approved Phase 3 15663-27-1 2767 441203 84093
20
Carboplatin Approved Phase 3,Phase 2,Phase 1 41575-94-4 10339178 38904 498142
21
Paclitaxel Approved, Vet_approved Phase 3,Phase 2 33069-62-4 36314
22
Mechlorethamine Approved, Investigational Phase 3,Phase 2,Phase 1 51-75-2 4033
23
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 3,Phase 1,Not Applicable 1177-87-3
24
Ifosfamide Approved Phase 3,Phase 2,Phase 1 3778-73-2 3690
25
Lenograstim Approved, Investigational Phase 3,Phase 2,Phase 1 135968-09-1
26
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 1,Not Applicable 50-02-2 5743
27
Vincristine Approved, Investigational Phase 3 2068-78-2, 57-22-7 5978
28
Promethazine Approved, Investigational Phase 3 60-87-7 4927
29
Mesna Approved, Investigational Phase 3 3375-50-6 598
30
Diphenhydramine Approved, Investigational Phase 3 147-24-0, 58-73-1 3100
31
Moxifloxacin Approved, Investigational Phase 3 354812-41-2, 151096-09-2 152946
32
Norgestimate Approved, Investigational Phase 3 35189-28-7 6540478
33
Ethinyl Estradiol Approved Phase 3 57-63-6 5991
34
Polyestradiol phosphate Approved Phase 3 28014-46-2
35
Estradiol Approved, Investigational, Vet_approved Phase 3 50-28-2 5757
36
Mycophenolic acid Approved Phase 3 24280-93-1 446541
37
Calcium Approved, Nutraceutical Phase 2, Phase 3,Phase 3,Phase 1,Not Applicable 7440-70-2 271
38
Folic Acid Approved, Nutraceutical, Vet_approved Phase 2, Phase 3,Phase 3,Phase 1 59-30-3 6037
39 Dermatologic Agents Phase 2, Phase 3,Phase 3,Not Applicable
40 Immunosuppressive Agents Phase 2, Phase 3,Phase 3,Phase 1,Not Applicable
41 Protective Agents Phase 2, Phase 3,Phase 3,Phase 1,Not Applicable
42 Antirheumatic Agents Phase 2, Phase 3,Phase 3,Not Applicable
43 Vitamin B9 Phase 2, Phase 3,Phase 3,Phase 1
44 Immunologic Factors Phase 2, Phase 3,Phase 3,Phase 1,Not Applicable
45 Vitamin B Complex Phase 2, Phase 3,Phase 3,Phase 1
46 Nucleic Acid Synthesis Inhibitors Phase 2, Phase 3,Phase 3
47 Antidotes Phase 2, Phase 3,Phase 3,Phase 1,Not Applicable
48 Antimetabolites, Antineoplastic Phase 2, Phase 3,Phase 3,Phase 1
49 Nutrients Phase 2, Phase 3,Phase 3,Phase 1
50 Calcium, Dietary Phase 2, Phase 3,Phase 3,Phase 1,Not Applicable

Interventional clinical trials:

(show top 50) (show all 93)
# Name Status NCT ID Phase Drugs
1 A Comparison of Single Versus Double Evacuation for Treatment of Hydatidiform Mole Recruiting NCT01630954 Phase 4
2 Surgery Plus Single Agent Chemotherapy Versus Primary Chemotherapy for Gestational Trophoblastic Neoplasms Unknown status NCT02606539 Phase 2, Phase 3 Methotrexate plus folinic acid alone
3 Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia Completed NCT00003702 Phase 3 Methotrexate
4 Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer Completed NCT00058071 Phase 3 amifostine trihydrate
5 Music Therapy or Book Discussion in Improving Quality of Life in Young Patients Undergoing Stem Cell Transplant Completed NCT00305851 Phase 3
6 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3 caspofungin acetate;liposomal amphotericin B
7 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3 liposomal amphotericin B
8 Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation Completed NCT00004230 Phase 3 captopril;cyclophosphamide
9 Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation Completed NCT00014391 Phase 3 ribavirin
10 Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation Completed NCT00003883 Phase 3 fluconazole;itraconazole
11 Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation Completed NCT00045292 Phase 3 acyclovir;acyclovir sodium;valacyclovir
12 RCT on the Efficacy of Methotrexate for the Prevention of GTD Completed NCT01984099 Phase 3 Methotrexate;Vitamin B Complex
13 Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors Completed NCT00053352 Phase 3 cisplatin;etoposide
14 Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor Recruiting NCT02639650 Phase 3 Etoposide;actinomycin D;methotrexate;vincristine;cyclophosphamide;Paclitaxel;Cisplatin;Carboplatin
15 Combination of Methotrexate(MTX) and Actinomycin(ACTD) in the Low Risk Gestational Trophoblastic Neoplasma (GTN) Patients With Score of 5-6 Recruiting NCT03885388 Phase 2, Phase 3 MTX;MTX+ACTD
16 Study of Hysteroscopic Repeat Curettage as the First-line Treatment in Low-risk Postmolar Gestational Trophoblastic Neoplasia Recruiting NCT03703271 Phase 3 Methotrexate
17 Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors Recruiting NCT02375204 Phase 3 paclitaxel;ifosfamide;cisplatin;pegylated G-CSF;G-CSF;carboplatin;etoposide phosphate
18 Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors Recruiting NCT03067181 Phase 3 Bleomycin;Carboplatin;Cisplatin;Etoposide;Etoposide Phosphate
19 Methotrexate Single-dose Treatment and Methotrexate/Actinomycin-D Single-dose Treatment in Low-Risk Gestational Trophoblastic Neoplasia Active, not recruiting NCT01823315 Phase 3 MTX 1;MTX 2
20 Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia Active, not recruiting NCT01535053 Phase 3 Leucovorin Calcium;Methotrexate
21 Rescue Regimen and High Dose Methotrexate in Management of Presistent Gestational Trophoplastic Neoplasia Not yet recruiting NCT03280979 Phase 2, Phase 3 rescue regimen;high dose methotrxate
22 Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant Terminated NCT00324324 Phase 3 moxifloxacin hydrochloride;Placebo
23 Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD) Terminated NCT00089141 Phase 3 mycophenolate mofetil;placebo
24 A Trial for Patients With Gestational Trophoblastic Disease Completed NCT00190918 Phase 2 Pemetrexed
25 Second Curettage in Treating Patients With Persistent Non-metastatic Gestational Trophoblastic Tumors Completed NCT00521118 Phase 2
26 Dactinomycin in Treating Patients With Persistent or Recurrent Gestational Trophoblastic Neoplasia Completed NCT00003688 Phase 2
27 Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant Completed NCT00410657 Phase 2 methylprednisolone;prednisone
28 Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors Completed NCT00004157 Phase 2
29 Campath-1H + FK506 and Methylprednisolone for GVHD Completed NCT00109993 Phase 2 methylprednisolone;tacrolimus
30 Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation Completed NCT00003887 Phase 2
31 Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon Completed NCT00010283 Phase 1, Phase 2 beclomethasone dipropionate
32 Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation Completed NCT00064311 Phase 1, Phase 2 ravuconazole
33 Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer Completed NCT00003408 Phase 2
34 Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer Completed NCT01764802 Phase 2
35 Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant Completed NCT00795769 Phase 2 ondansetron
36 Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant Completed NCT00110045 Phase 2 caspofungin acetate
37 Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant Completed NCT00357084 Phase 2 methotrexate;methylprednisolone;prednisone
38 Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation Completed NCT00002673 Phase 2
39 Single Patient Treatment Protocol of TRC105 Combined With Standard-dose Bevacizumab for a Single Patient With Metastatic And Refractory Choriocarcinoma Completed NCT02396511 Phase 2
40 Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors Completed NCT00467051 Phase 2 Carboplatin;Ifosfamide;Paclitaxel
41 Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Recruiting NCT02834013 Phase 2
42 Avelumab in Chemo-resistant Gestational Trophoblastic Neoplasias Recruiting NCT03135769 Phase 2 Avelumab administration at 10mg/kg
43 Role of Axumin PET Scan in Germ Cell Tumor Recruiting NCT03426865 Phase 2 Axumin PET scan
44 Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Low-Risk Gestational Trophoblastic Tumor After a Molar Pregnancy Terminated NCT00096187 Phase 2 pemetrexed disodium
45 Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN) Terminated NCT02664961 Phase 2 TRC105;Bevacizumab
46 Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload Terminated NCT01159067 Phase 2 deferasirox
47 Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions Unknown status NCT00066404 Phase 1
48 Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections Unknown status NCT00769613 Phase 1
49 Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors Completed NCT00003107 Phase 1
50 Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia Completed NCT01484015 Phase 1 cefepime hydrochloride

Search NIH Clinical Center for Trophoblastic Neoplasm

Inferred drug relations via UMLS 74 / NDF-RT 52 :


Cochrane evidence based reviews: trophoblastic neoplasms

Genetic Tests for Trophoblastic Neoplasm

Anatomical Context for Trophoblastic Neoplasm

MalaCards organs/tissues related to Trophoblastic Neoplasm:

42
Placenta, Bone Marrow, Brain, T Cells, Colon, Spinal Cord, Appendix

Publications for Trophoblastic Neoplasm

Articles related to Trophoblastic Neoplasm:

(show top 50) (show all 93)
# Title Authors Year
1
Role of salvage therapy in chemo resistant or recurrent high-risk gestational trophoblastic neoplasm. ( 30700567 )
2019
2
Gestational trophoblastic neoplasms (GTNs) do not display epithelial-to-mesenchymal transition (EMT) features. ( 30847562 )
2019
3
Serum angiogenesis profile in gestational trophoblastic neoplasm using multiplex immunoassay. ( 30195618 )
2018
4
A pilot randomized controlled clinical trial of second uterine curettage versus usual care to determine the effect of re-curettage on patients' need for chemotherapy among women with low risk, nonmetastatic gestational trophoblastic neoplasm in Urmia, Iran. ( 29033610 )
2017
5
Unusual Presentation of Hypothyroidism in a Pregnant Woman, Mimicking Gestational Trophoblastic Neoplasm. ( 27034864 )
2016
6
Tegafur Substitution for 5-Fu in Combination with Actinomycin D to Treat Gestational Trophoblastic Neoplasm. ( 26599757 )
2015
7
Gestational trophoblastic neoplasm and women living with HIV and/or AIDS. ( 29568578 )
2015
8
Resistance to single-agent chemotherapy and its risk factors in low-risk gestational trophoblastic neoplasms. ( 25492546 )
2015
9
A well-circumscribed border with peripheral Doppler signal in sonographic image distinguishes epithelioid trophoblastic tumor from other gestational trophoblastic neoplasms. ( 25396428 )
2014
10
Klippel-Trenaunay syndrome and gestational trophoblastic neoplasm. ( 25228614 )
2014
11
Uterine rupture due to invasive metastatic gestational trophoblastic neoplasm. ( 24106538 )
2013
12
Withdrawn: Retraction notice to "Minimally-aggressive gestational trophoblastic neoplasms" [Gynecol Oncol 125 (2012) 145-150]. ( 23499417 )
2013
13
Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study. ( 22055909 )
2012
14
Minimally-aggressive gestational trophoblastic neoplasms. ( 22198244 )
2012
15
Major surgeries performed for gestational trophoblastic neoplasms in a teaching hospital in Tehran, Iran. ( 21860735 )
2011
16
Lack of a y-chromosomal complement in the majority of gestational trophoblastic neoplasms. ( 20182630 )
2010
17
Trophoblastic neoplasms express fatty acid synthase, which may be a therapeutic target via its inhibitor C93. ( 19893031 )
2009
18
Patients with presenting unusual manifestations with gestational trophoblastic neoplasm: case series and review of literatures. ( 17940785 )
2008
19
Two rare cases of methotrexate-induced pneumonitis and pleurisy in patients with gestational trophoblastic neoplasms. ( 18714577 )
2008
20
Successful treatment of two patients with gestational trophoblastic neoplasm presenting with emergent neurologic symptoms. ( 16681792 )
2006
21
Successful treatment of a patient with gestational trophoblastic neoplasm metastatic to the colon. ( 16263566 )
2005
22
Genetic origin of malignant trophoblastic neoplasms analyzed by sequence tag site polymorphic markers. ( 11330958 )
2001
23
Expression of CDKI p27Kip1 in trophoblastic neoplasm. ( 11776123 )
2000
24
MR appearance of placental site gestational trophoblastic neoplasm. ( 8846312 )
1996
25
In vitro chemosensitivity of paclitaxel and other chemotherapeutic agents in malignant gestational trophoblastic neoplasms. ( 7756689 )
1995
26
Malignant trophoblastic neoplasms with different modes of origin. ( 8536237 )
1995
27
Metastatic trophoblastic neoplasm: Report of a case with a delay in diagnosis resulting from an unusual presentation. ( 7520498 )
1994
28
Detection of placental growth hormone variant and chorionic somatomammotropin ribonucleic acid expression in human trophoblastic neoplasms by reverse transcriptase-polymerase chain reaction. ( 7515000 )
1994
29
Genetic origin of malignant trophoblastic neoplasms. ( 8174097 )
1994
30
[Expression of human chorionic gonadotropin, human placental lactogen and pregnancy-specific 1-glycoprotein in malignant trophoblastic neoplasms]. ( 7712876 )
1994
31
Nonmetastatic gestational trophoblastic neoplasms. ( 8381373 )
1993
32
Gestational and non-gestational trophoblastic neoplasms: new developments in DNA analysis, metabolic function, diagnosis and treatment. ( 8400045 )
1993
33
Pulmonary disease in gestational trophoblastic neoplasms. ( 1324326 )
1992
34
The expression of human chorionic gonadotropin/human luteinizing hormone receptors in human gestational trophoblastic neoplasms. ( 1592864 )
1992
35
[Immunocytochemical localization of human chorionic gonadotropin and placental lactogen in gestational trophoblastic neoplasms]. ( 1337871 )
1992
36
Successful treatment of refractory gestational trophoblastic neoplasm with high-dose etoposide and cyclophosphamide. ( 1661266 )
1991
37
Metastatic adnexal trophoblastic neoplasm: contribution of MR imaging. ( 2846661 )
1988
38
Immunohistochemistry of germ cell and trophoblastic neoplasms. ( 2457424 )
1988
39
Update in cancer chemotherapy: genitourinary tract cancer, Part 7: Gestational trophoblastic neoplasms. ( 2841462 )
1988
40
Gestational trophoblastic neoplasms: history of the current understanding. ( 2852327 )
1988
41
Trophoblastic neoplasms: occult disease. ( 2852336 )
1988
42
Gestational trophoblastic neoplasm of the uterus: MR assessment. ( 3020607 )
1986
43
Gestational trophoblastic neoplasms. ( 3003297 )
1986
44
Chemotherapy for trophoblastic neoplasms in the Philippines. ( 3012792 )
1985
45
Epidemiology of gestational trophoblastic neoplasm at the Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia. ( 6093460 )
1984
46
Metastatic gestational trophoblastic neoplasm. A study of two cases in unusual clinical settings and review of the literature. ( 6094315 )
1984
47
Reevaluation of 5-fluorouracil as a single therapeutic agent for gestational trophoblastic neoplasms. ( 6089563 )
1984
48
A proposal on the clinical staging of malignant trophoblastic neoplasms based on the study of process of development of the disease. ( 6093466 )
1984
49
The role of methotrexate in the chemotherapy of gestational trophoblastic neoplasms. ( 6093467 )
1984
50
Re-evaluation of 5-fluorouracil as a single agent for gestational malignant trophoblastic neoplasms. ( 6093468 )
1984

Variations for Trophoblastic Neoplasm

Expression for Trophoblastic Neoplasm

Search GEO for disease gene expression data for Trophoblastic Neoplasm.

Pathways for Trophoblastic Neoplasm

GO Terms for Trophoblastic Neoplasm

Cellular components related to Trophoblastic Neoplasm according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.02 CGA CSH1 GAL INHA LNPEP

Biological processes related to Trophoblastic Neoplasm according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 SMAD protein signal transduction GO:0060395 8.96 INHA LNPEP
2 regulation of signaling receptor activity GO:0010469 8.92 CGA CSH1 GAL INHA

Molecular functions related to Trophoblastic Neoplasm according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 hormone activity GO:0005179 8.92 CGA CSH1 GAL INHA

Sources for Trophoblastic Neoplasm

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....